Alkem Laboratories (NSE:ALKEM) Interest Expense: ₹-1,608 Mil (TTM As of Mar. 2026)


NSE:ALKEM Alkem Laboratories Ltd NSE:ALKEM
96 GF Score
Price ₹5,648.50
GF Value ₹6,092.66
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Alkem Laboratories Interest Expense?

Alkem Laboratories NSE:ALKEM +0.76% 96 Interest Expense is ₹-1,608 Mil as of Mar. 2026. GuruFocus rates NSE:ALKEM with a GF Score™ of 96/100 and a GF Value™ of ₹6,092.66 (Fairly Valued). The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Alkem Laboratories's interest expense for the three months ended in Mar. 2026 was ₹ -539 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-1,608 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Alkem Laboratories's Operating Income for the three months ended in Mar. 2026 was ₹ 4,116 Mil. Alkem Laboratories's Interest Expense for the three months ended in Mar. 2026 was ₹ -539 Mil. Alkem Laboratories's Interest Coverage for the quarter that ended in Mar. 2026 was 7.64. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alkem Laboratories  (NSE:ALKEM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alkem Laboratories's Interest Expense for the three months ended in Mar. 2026 was ₹-539 Mil. Its Operating Income for the three months ended in Mar. 2026 was ₹4,116 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ₹8,692 Mil.

Alkem Laboratories's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*4116.3/-538.8
=7.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Alkem Laboratories Interest Expense Historical Data

* Premium members only.

The historical data trend for Alkem Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkem Laboratories Interest Expense Chart

Alkem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -408.40 -937.50 -957.10 -1,217.00 -1,607.80

Alkem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -284.20 -297.80 -350.20 -421.00 -538.80
NSE:ALKEM
96GF Score
Alkem Laboratories Ltd NSE:ALKEM
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkem Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1,608 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-1,608 Mil mean?
Alkem Laboratories (NSE:ALKEM) has a Interest Expense of ₹-1,608 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Alkem Laboratories and its competitors.
Is Alkem Laboratories' Interest Expense too high?
Alkem Laboratories' current Interest Expense is ₹-1,608 Mil. Overall, Alkem Laboratories has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alkem Laboratories' Interest Expense compare to ZTS and UTHR?
Alkem Laboratories' Interest Expense of ₹-1,608 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Alkem Laboratories and its competitors. Alkem Laboratories's current Interest Expense is ₹-1,608 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alkem Laboratories (NSE:ALKEM) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,092.66, compared to a current price of ₹5,648.50 — trading 7.3% below its estimated fair value. The current Interest Expense is ₹-1,608 Mil. Alkem Laboratories' overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Alkem Laboratories (NSE:ALKEM), the current Interest Expense is ₹-1,608 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkem Laboratories (NSE:ALKEM) Overvalued in 2026?

Based on GuruFocus' analysis, Alkem Laboratories stock appears to be undervalued. The current stock price of ₹5,648.50 is trading 7.3% below its estimated GF Value™ of ₹6,092.66. GuruFocus considers Alkem Laboratories to be Fairly Valued.

Key valuation signals for NSE:ALKEM:

  • Interest Expense: ₹-1,608 Mil
  • GF Value™: ₹6,092.66 vs. price of ₹5,648.50 (7.3% below fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the NSE:ALKEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkem Laboratories Business Description

Other Exchanges 539523:India
Address Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
96GF Score

Get the complete analysis for NSE:ALKEM

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,648.50
Price
₹6,092.66
GF Value